Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q2 2022 Results - Earnings Call Transcript
12:17pm, Sunday, 07'th Aug 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Off
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 Earnings and Revenues Beat Estimates
07:33pm, Thursday, 04'th Aug 2022
Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 20% and 3.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for th
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022
05:58am, Saturday, 23'rd Jul 2022
Each of these stocks is ready for a rebound.
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 4, 2022
08:00am, Tuesday, 19'th Jul 2022
SAN DIEGO, July 19, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q1 2022 Results - Earnings Call Transcript
08:13pm, Sunday, 08'th May 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Office
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
08:18pm, Thursday, 05'th May 2022
Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 25.58% and 6.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead fo
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 5, 2022
05:01pm, Thursday, 21'st Apr 2022
SAN DIEGO, April 21, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans
Maravai LifeSciences Announces March 2022 Investor Conference Schedule
04:30pm, Wednesday, 09'th Mar 2022
SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to
Sail Through the Choppy Market With These 4 Low-Beta Stocks
09:14am, Friday, 04'th Mar 2022
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Meridian (VIVO), Innoviva (INVA), Horace (HMN) and Maravai LifeSciences (MRVI) are well poised to gain.
Exclusive-Sartorius in $11 billion bid for COVID vaccine reagent vendor Maravai -sources
08:24pm, Friday, 25'th Feb 2022 FX Empire
By Greg Roumeliotis (Reuters) – Laboratory supplies vendor Sartorius AG has approached Maravai LifeSciences Holdings Inc, a U.S. provider of capping reagents for COVID-19 vaccines, with an $11 billion acquisition offer, people familiar with the matter said.
Maravai LifeSciences surges as Sartorius makes $11B bid (NASDAQ:MRVI)
08:11pm, Friday, 25'th Feb 2022 Seeking Alpha
Maravai LifeSciences <> shares have surged after Reuters reported that German-based lab supplies vendor, Sartorius (SARTF) made an $11B acquisition offer for the U.S.-based…
Maravai Life Sciences stocks jumps on report of $11B bid from Sartorius
08:10pm, Friday, 25'th Feb 2022 Seeking Alpha
Maravai Life Sciences (MRVI) soared 17% after a report that Sartorius AG offered to buy the the company for $11B.Maravai rejected the $42/share offer from Goettingen,…
Can Maravai LifeSciences Holdings, Inc. (MRVI) Run Higher on Rising Earnings Estimates?
01:50pm, Friday, 25'th Feb 2022
Maravai LifeSciences Holdings, Inc. (MRVI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Can Maravai LifeSciences Holdings, Inc. (MRVI) Climb 56% to Reach the Level Wall Street Analysts Expect?
11:35am, Thursday, 24'th Feb 2022
The consensus price target hints at a 55.8% upside potential for Maravai LifeSciences Holdings, Inc. (MRVI). While empirical research shows that this sought-after metric is hardly effective, an upward
